HIV-1 envelope resistance to proteasomal cleavage: implications for vaccine induced immune responses.
Antigen processing involves many proteolytic enzymes such as proteasomes and cathepsins. The processed antigen is then presented on the cell surface bound to either MHC class I or class II molecules and induces/interacts with antigen-specific CD8+ and CD4+ T-cells, respectively. Preliminary immunolo...
Main Authors: | Nicholas J Steers, Silvia Ratto-Kim, Mark S de Souza, Jeffrey R Currier, Jerome H Kim, Nelson L Michael, Carl R Alving, Mangala Rao |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3412807?pdf=render |
Similar Items
-
The VHSE-based prediction of proteasomal cleavage sites.
by: Jiangan Xie, et al.
Published: (2013-01-01) -
Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant
by: Oscar B. Torres, et al.
Published: (2017-05-01) -
Computational analysis and modeling of cleavage by the immunoproteasome and the constitutive proteasome
by: Lafuente Esther M, et al.
Published: (2010-09-01) -
Decreased proteasomal cleavage at nitrotyrosine sites in proteins and peptides
by: Christiane Ott, et al.
Published: (2021-10-01) -
The prokaryotic ubiquitin-like protein presents poor cleavage sites for proteasomal degradation
by: Erez Zerbib, et al.
Published: (2021-07-01)